In Silico Multitarget Profiling of Betulinic Acid: ADME/Protox-II Toxicity, Network Pharmacology, and Molecular Docking for Diabetic Osteoporosis.
BA is a secure multi-target treatment option for DO, providing molecular insights for forthcoming experimental validation and multi-target interactions of BA, especially with key signaling pathways, indicate a broad involvement in the metabolic and inflammatory processes contributing to the development of DO.